Back to search
federal
501(c)(3) required
HealthAmyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
National Institutes of Health
Funding amount
Varies
Deadline
Nov 10, 2026
Geography
National (all U.S.)
Analyzing this grant for you…
About this grant
Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
Eligibility
See opportunity page for eligibility details.
Required documents
- SF-424
- Project narrative
- Budget
Eligible organization types
Nonprofit
Always verify grant requirements directly with the funder before applying.